共 54 条
[1]
Torre LA(2015)Global cancer statistics, 2012 CA: a cancer journal for clinicians. 65 87-108
[2]
Bray F(2000)Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma Ann Surg. 232 10-24
[3]
Siegel RL(2011)Hepatic resection for hepatocellular carcinoma with lymph node metastasis: clinicopathological analysis and survival outcome Asian J. 34 53-62
[4]
Ferlay J(2007)Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes Surgery. 141 330-339
[5]
Lortet-Tieulent J(2007)Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma Am J Surg. 194 17-22
[6]
Jemal A(2009)Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies Liver international : official journal of the International Association for the Study of the Liver. 29 502-510
[7]
Tung-Ping Poon R(2014)Cytohesin-3 is upregulated in hepatocellular carcinoma and contributes to tumor growth and vascular invasion International journal of clinical and experimental pathology. 7 2123-2132
[8]
Fan ST(2017)Metabolomic characterization of hepatocellular carcinoma in patients with liver cirrhosis for biomarker discovery Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 26 675-683
[9]
Wong J(2018)A large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma Hepatology. 67 662-675
[10]
Lee CW(2018)Aberrant metabolism in hepatocellular carcinoma provides diagnostic and therapeutic opportunities Oxidative medicine and cellular longevity. 2018 7512159-2703